Broad-Spectrum Profiling of Drug Safety via Learning Complex Network

Ke Liu, Ruo Fan Ding, Han Xu, Yang Mei Qin, Qiu Shun He, Fei Du, Yun Zhang, Li Xia Yao, Pan You, Yan Ping Xiang, Zhi Liang Ji

Research output: Contribution to journalArticle

Abstract

Drug safety is a severe clinical pharmacology and toxicology problem that has caused immense medical and social burdens every year. Regretfully, a reproducible method to assess drug safety systematically and quantitatively is still missing. In this study, we developed an advanced machine learning model for de novo drug safety assessment by solving the multilayer drug-gene-adverse drug reaction (ADR) interaction network. For the first time, the drug safety was assessed in a broad landscape of 1,156 distinct ADRs. We also designed a parameter ToxicityScore to quantify the overall drug safety. Moreover, we determined association strength for every 3,807,631 gene-ADR interactions, which clues mechanistic exploration of ADRs. For convenience, we deployed the model as a web service ADRAlert-gene at http://www.bio-add.org/ADRAlert/. In summary, this study offers insights into prioritizing safe drug therapy. It helps reduce the attrition rate of new drug discovery by providing a reliable ADR profile in the early preclinical stage.

Original languageEnglish (US)
Pages (from-to)1373-1382
Number of pages10
JournalClinical pharmacology and therapeutics
Volume107
Issue number6
DOIs
StatePublished - Jun 1 2020

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Broad-Spectrum Profiling of Drug Safety via Learning Complex Network'. Together they form a unique fingerprint.

  • Cite this

    Liu, K., Ding, R. F., Xu, H., Qin, Y. M., He, Q. S., Du, F., Zhang, Y., Yao, L. X., You, P., Xiang, Y. P., & Ji, Z. L. (2020). Broad-Spectrum Profiling of Drug Safety via Learning Complex Network. Clinical pharmacology and therapeutics, 107(6), 1373-1382. https://doi.org/10.1002/cpt.1750